Chemotherapy, nerve injuries, or diseases like multiple sclerosis can cause pathophysiological processes of persistent and neuropathic pain. Thereby, the activation threshold of ion channels is reduced in peripheral sensory neurons to normally noxious stimuli like heat, cold, acid, or mechanical due to sensitization processes. This leads to enhanced neuronal activity, which can result in mechanical allodynia, cold allodynia, thermal hyperalgesia, spontaneous pain, and may initiate persistent and neuropathic pain. The treatment options for persistent and neuropathic pain patients are limited; for about 50% of them, current medication is not efficient due to severe side effects or low response to the treatment. Therefore, it is of special interest to find additional treatment strategies. One approach is the control of neuronal sensitization processes. Herein, signaling lipids are crucial mediators and play an important role during the onset and maintenance of pain. As preclinical studies demonstrate, lipids may act as endogenous ligands or may sensitize transient receptor potential (TRP)-channels. Likewise, they can cause enhanced activity of sensory neurons by mechanisms involving G-protein coupled receptors and activation of intracellular protein kinases. In this regard, oxidized metabolites of the essential fatty acid linoleic acid, 9- and 13-hydroxyoctadecadienoic acid (HODE), their dihydroxy-metabolites (DiHOMEs), as well as epoxides of linoleic acid (EpOMEs) and of arachidonic acid (EETs), as well as lysophospholipids, sphingolipids, and specialized pro-resolving mediators (SPMs) have been reported to play distinct roles in pain transmission or inhibition. Here, we discuss the underlying molecular mechanisms of the oxidized linoleic acid metabolites and eicosanoids. Furthermore, we critically evaluate their role as potential targets for the development of novel analgesics and for the treatment of persistent or neuropathic pain.
Keywords: HODE; eicosanoids; linoleic acid metabolites; lipids inflammatory pain; neuropathic pain; pain; transient receptor potential channels.
Copyright © 2019 Osthues and Sisignano.
Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia.Version 2. Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18820-4. doi: 10.1073/pnas.0905415106. Epub 2009 Oct 20. Proc Natl Acad Sci U S A. 2009. PMID: 19843694 Free PMC article.
Beyond the classic eicosanoids: Peripherally-acting oxygenated metabolites of polyunsaturated fatty acids mediate pain associated with tissue injury and inflammation.Prostaglandins Leukot Essent Fatty Acids. 2016 Aug;111:45-61. doi: 10.1016/j.plefa.2016.03.001. Epub 2016 Mar 9. Prostaglandins Leukot Essent Fatty Acids. 2016. PMID: 27067460 Review.
Synthesis of lipid mediators during UVB-induced inflammatory hyperalgesia in rats and mice.PLoS One. 2013 Dec 9;8(12):e81228. doi: 10.1371/journal.pone.0081228. eCollection 2013. PLoS One. 2013. PMID: 24349046 Free PMC article.
The oxidized linoleic acid metabolite 12,13-DiHOME mediates thermal hyperalgesia during inflammatory pain.Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jul;1863(7):669-678. doi: 10.1016/j.bbalip.2018.03.012. Epub 2018 Apr 4. Biochim Biophys Acta Mol Cell Biol Lipids. 2018. PMID: 29625231
TRP-channels as key integrators of lipid pathways in nociceptive neurons.Prog Lipid Res. 2014 Jan;53:93-107. doi: 10.1016/j.plipres.2013.11.002. Epub 2013 Nov 25. Prog Lipid Res. 2014. PMID: 24287369 Review.